Finding the best thresholds of FEV1and dyspnea to predict 5-year survival in COPD patients: The COCOMICS study

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Almagro, Pere ^a   Martinez Camblor, Pablo ^b   Soriano, Joan B ^c   Marin, Jose M ^d   Alfageme, Inmaculada ^e   Casanova, Ciro ^f   Esteban, Cristobal ^g   Soler Cataluña, Juan J ^h   De Torres, Juan P ⁱ   Celli, Bartolome R ^j   Miravitlles, Marc ^k  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b Asturias Biomedical Research Office   (Spain)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^d HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^e HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^f HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^g HOSPITAL DE GALDAKAO   (Spain)

^h HOSPITAL ARNAU DE VILANOVA   (Spain)

ⁱ UNIVERSITY CLINIC OF NAVARRA   (Spain)

^j HARVARD UNIVERSITY   (United States)

^k HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROGNOSIS; SPIROMETRY; SURVIVAL RATE; SURVIVAL TIME;

AGED; AREA UNDER CURVE; COHORT STUDIES; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPAIN; SPIROMETRY; SURVIVAL ANALYSIS;

EID: 84896105759     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089866     Document Type: Article

References (50)

1. Murray CJ, Vos T, Lozano R, Naqhavi M, Flaxman AD, et al (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2197-223.
2. Lozano R, Naghavi M, Foreman K, Kim S, Shibuya K, et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. 380:2095-128.
3. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, et al (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187:347-65.
4. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, et al (2004). The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350:1005-1012. (Pubitemid 38269277)
5. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, et al (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:581-586. (Pubitemid 29296676)
6. Soler-Cataluna JJ, Martinez-Garcia MA, Sanchez LS, Tordera MO, Sanchez PR (2009) Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med 103:692-699.
7. Puhan MA, Garcia-Aymerich J, Frey M, ter Riet G, Anto JM, et al (2009) Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 374:704-711.
8. Azarisman MS, Fauzi MA, Faizal MP, Azami Z, Roslina AM, et al (2007) The SAFE (SGRQ score, air-flow limitation and exercise tolerance) index: a new composite score for the stratification of severity in chronic obstructive pulmonary disease. Postgrad Med J 83:492-497. (Pubitemid 47123323)
9. Jones RC, Donaldson GC, Chavannes NH, Kida K, Dickson-Spillmann M, et al (2009) Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease - the dose index. Am J Respir Crit Care Med 180:1189-1195.
10. Marin JM, Alfageme I, Almagro P, Casanova C, Esteban C, et al (2013) Multicomponent indices to predict survival in COPD: The COllaborative COhorts to assess multicomponent indices of COPD in Spain-COCOMICS study. Eur Respir J 42:323-32.
11. BTS guidelines for the management of chronic obstructive pulmonary disease (1997) The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 52 Suppl 5:S1-28.
12. Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, et al. (2012) Pharmacological treatment of stable COPD. Arch Bronconeumol 48: 247-257
13. Celli BR, MacNee W (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23:932-946. (Pubitemid 38807371)
14. Burgel PR, Paillasseur JL, Peene B, Dusser D, Roche N, et al (2012) Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality. PLoS One 7:e51048.
15. Nishimura K, Izumi T, Tsukino M, Oga T (2002) Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121:1434-40. (Pubitemid 34499652)
16. Oga T, Tsukino M, Hajiro T, Ikeda A, Nishimura K (2012) Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study. Respir Res 13:85.
17. Soriano JB, Alfageme I, Almagro P, Casanova C, Esteban C, et al (2013) Distribution and prognostic validity of the new global initiative for chronic obstructive lung disease grading classification. Chest 143:694-702.
18. Esteban C, Quintana JM, Aburto M, Moraza J, Egurrola M, et al (2008) Predictors of mortality in patients with stable COPD. J Gen Intern Med 23:1829-34.
19. de Torres JP, Bastarrika G, Zagaceta J, Sáiz-Mendiguren R, Alcaide AB, et al (2011) Emphysema presence, severity, and distribution has little impact on the clinical presentation of a cohort of patients with mild to moderate COPD. Chest 139:36-42.
20. Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, et al (2005) Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60:925-31. (Pubitemid 41598207)
21. Alfageme I, Reyes N, Merino M, Reina A, Gallego J, et al (2010) The effect of airflow limitation on the cause of death in patients with COPD. Chron Respir Dis 7:135-45.
22. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, et al (2005) Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171:591-7. (Pubitemid 40365414)
23. Almagro P, Calbo E, Ochoa de Echagüen A, Barreiro B, Quintana S, et al (2002) Mortality after hospitalization for COPD. Chest 121:1441-8. (Pubitemid 34499653)
24. Sanjaume M, Almagro P, Rodríguez-Carballeira M, Barreiro B, Heredia JL, et al (2009) Post-hospital mortality in patients re-admitted due to COPD. Utility of BODE index.Rev Clin Esp 209:364-70.
25. Almagro P, Salvadó M, Garcia-Vidal C, Rodríguez-Carballeira M, Cuchi E, et al (2012) Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease. Respiration 84:36-43.14
26. Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR (2010) Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 182:325-31.
27. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al (2005) Standardisation of spirometry. Eur Respir J 26:319-338. (Pubitemid 41079078)
28. Charlson ME, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47:1245-1251. (Pubitemid 24361532)
29. Cox DR, Oakes D (1984) Analysis of Survival Data. London, England: Chapman & Hall.
30. Heagerty PJ, Zheng Y (2005) Survival model predictive accuracy and ROC curves. Biometrics 61:92-105. (Pubitemid 40380968)
31. Martínez-Camblor P, Corral N (2012) A general bootstrap algorithm for hypothesis testing. J Statist Plann Inference 142:589-600.
32. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, et al (1996) Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 313:711-5.
33. Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, et al (2011) Changes in forced expiratory volume in 1 second overtime in COPD. N Engl J Med 365:1184-92.
34. Postma DS, Sluiter HJ (1989) Prognosis of chronic obstructive pulmonary disease: the Dutch experience. Am Rev Respir Dis 140:S100-5. (Pubitemid 19231344)
35. Puhan MA, Hansel NN, Sobradillo P, Enright P, Lange P, et al (2012) Large-scale international validation of the ADO index in subjects with COPD: an individual subject data analysis of 10 cohorts. BMJ Open 2.e002152.
36. Kim S, Oh J, Kim YI, Ban HJ, Kwon YS, et al (2013) Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses. BMC Pulm Med 13:35.
37. Johannessen A, Nilsen RM, Storebø M, Gulsvik A, Eagan T, et al (2013) Comparison of 2011 and 2007 GOLD Guidelines for Predicting Mortality and Hospitalization. Am J Respir Crit Care Med 188:602-8
38. Lange P, Marott JL, Vestbo J, Olsen KR, Ingebrigtsen TS, et al (2012) Prediction of the Clinical Course of Chronic Obstructive Pulmonary Disease, Using the New GOLD Classification. Am J Respir Crit Care Med 186:975-981.
39. Agusti A, Edwards LD, Celli B, Macnee W, Calverley PM, et al (2013) Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur Respir J. 42:636-46.
40. Díez-Manglano J, Barquero-Romero J, Almagro P, Cabrera FJ, Lopez-Garcia F, et al (2013) COPD patients with and without metabolic syndrome: clinical and functional differences. Intern Emerg Med [Epub ahead of print]
41. Clini EM, Beghé B, Fabbri LM (2013) Chronic obstructive pulmonary disease is just one component of the complex multimorbidities in patients with COPD. Am J Respir Crit Care Med 187:668-71.
42. Almagro P, Cabrera FJ, Diez J, Boixeda R, Alonso-Ortiz B, et al (2012). Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD. The ESMI study. Chest 142:1126-33.
43. Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, et al (2013) Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187:728-35.
44. Müllerova H, Agusti A, Erqou S, Mapel DW (2013) Cardiovascular comorbidity in chronic obstructive pulmonary disease: systematic literature review. Chest 144:1163-78.
45. Yu D, Simmons D (2013) Association between lung capacity measurements and abnormal glucose metabolism: findings from the Crossroads study. Diabet Med [Epub ahead of print]
46. Nourizadeh M, Ghelich Y, Amin A, Eidani E, Gholampoor Y, et al (2013) Study the mechanical pulmonary changes in patients with congestive heart failure (CHF) by impulse oscillometry. J Cardiovasc Dis Res 4:130-3.
47. Moayyeri A, Bingham SA, Luben RN, Wareham NJ, Khaw KT (2009) Respiratory function as a marker of bone health and fracture risk in an older population. J Bone Miner Res 24:956-63.
48. Johnson LS, Juhlin T, Engström G, Nilsson PM (2013) Reduced forced expiratory volume is associated with increased incidence of atrial fibrillation: the Malmo Preventive Project. Europace [Epub ahead of print]
49. Baughman P,Marott JL, Lange P, Martin CJ, Shankar A, et al (2012) Combined effect of lung function level and decline increases morbidity and mortality risks. Eur J Epidemiol 27:933-43.
50. Miravitlles M, Soriano JB, García-Río F, Muñoz L, Duran-Tauleria E, et al (2009) Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activities. Thorax 64:863-868.